Literature DB >> 12909718

Nuclear import of hepatitis B virus capsids and release of the viral genome.

Birgit Rabe1, Angelika Vlachou, Nelly Panté, Ari Helenius, Michael Kann.   

Abstract

While studying the import of the hepatitis B virus genome into the nucleus of permeabilized tissue culture cells, we found that viral capsids were imported in intact form through the nuclear pore into the nuclear basket. Import depended on phosphorylation of the capsid protein and was mediated by the cellular transport receptors importin alpha and beta. Virus-derived capsids that contained the mature viral genome were able to release the viral DNA and capsid protein into the nucleoplasm. The uncoating reaction was independent of Ran, a GTP-binding enzyme responsible for dissociating other imported cargo from the inner face of the nuclear pore. Immature capsids that did not contain the mature viral genome reached the basket but did not release capsid proteins nor immature genomes into the nucleoplasm. The different fate of mature and immature capsids after passing the nuclear pore indicates that the outcome of a nuclear import event may be regulated within the nuclear basket.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12909718      PMCID: PMC187862          DOI: 10.1073/pnas.1730940100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Core protein phosphorylation modulates pregenomic RNA encapsidation to different extents in human and duck hepatitis B viruses.

Authors:  E V Gazina; J E Fielding; B Lin; D A Anderson
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm.

Authors:  Nelly Panté; Michael Kann
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

3.  Characterization of the nuclear import pathway for HIV-1 integrase.

Authors:  C Depienne; A Mousnier; H Leh; E Le Rouzic; D Dormont; S Benichou; C Dargemont
Journal:  J Biol Chem       Date:  2001-03-16       Impact factor: 5.157

4.  Does a cdc2 kinase-like recognition motif on the core protein of hepadnaviruses regulate assembly and disintegration of capsids?

Authors:  M I Barrasa; J T Guo; J Saputelli; W S Mason; C Seeger
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

5.  HBs-Ag, HBc-Ag and virus-like particles in liver tissue.

Authors:  S Furuta; A Nagata; K Kiyosawa; T Takahashi; Y Akahane
Journal:  Gastroenterol Jpn       Date:  1975

6.  Pattern of core and surface expression in liver tissue reflects state of specific immune response in hepatitis B.

Authors:  F Gudat; L Bianchi; W Sonnabend; G Thiel; W Aenishaenslin; G A Stalder
Journal:  Lab Invest       Date:  1975-01       Impact factor: 5.662

7.  Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein.

Authors:  Henrik Daub; Stephanie Blencke; Peter Habenberger; Alexander Kurtenbach; Julia Dennenmoser; Josef Wissing; Axel Ullrich; Matt Cotten
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Evolutionary conservation in the hepatitis B virus core structure: comparison of human and duck cores.

Authors:  J M Kenney; C H von Bonsdorff; M Nassal; S D Fuller
Journal:  Structure       Date:  1995-10-15       Impact factor: 5.006

9.  Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions.

Authors:  M A Sells; A Z Zelent; M Shvartsman; G Acs
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

10.  Inhibition of in vitro nuclear transport by a lectin that binds to nuclear pores.

Authors:  D R Finlay; D D Newmeyer; T M Price; D J Forbes
Journal:  J Cell Biol       Date:  1987-02       Impact factor: 10.539

View more
  117 in total

1.  Identification of disubstituted sulfonamide compounds as specific inhibitors of hepatitis B virus covalently closed circular DNA formation.

Authors:  Dawei Cai; Courtney Mills; Wenquan Yu; Ran Yan; Carol E Aldrich; Jeffry R Saputelli; William S Mason; Xiaodong Xu; Ju-Tao Guo; Timothy M Block; Andrea Cuconati; Haitao Guo
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

Review 2.  Metabolism and function of hepatitis B virus cccDNA: Implications for the development of cccDNA-targeting antiviral therapeutics.

Authors:  Ju-Tao Guo; Haitao Guo
Journal:  Antiviral Res       Date:  2015-08-10       Impact factor: 5.970

3.  Analyses of phosphorylation events in the rubella virus capsid protein: role in early replication events.

Authors:  LokMan J Law; Carolina S Ilkow; Wen-Pin Tzeng; Matthew Rawluk; David T Stuart; Teryl K Frey; Tom C Hobman
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 4.  Intracellular transport of hepatitis B virus.

Authors:  Michael Kann; Andre Schmitz; Birgit Rabe
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

5.  Adenovirus core protein pVII is translocated into the nucleus by multiple import receptor pathways.

Authors:  Harald Wodrich; Aurelia Cassany; Maximiliano A D'Angelo; Tinglu Guan; Glen Nemerow; Larry Gerace
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

6.  Molecular dissection of nuclear entry-competent SV40 during infection.

Authors:  Akira Nakanishi; Peggy P Li; Qiumin Qu; Qumber H Jafri; Harumi Kasamatsu
Journal:  Virus Res       Date:  2006-11-16       Impact factor: 3.303

Review 7.  Hepatitis B virus morphogenesis.

Authors:  Volker Bruss
Journal:  World J Gastroenterol       Date:  2007-01-07       Impact factor: 5.742

Review 8.  Revisiting Hepatitis B Virus: Challenges of Curative Therapies.

Authors:  Jianming Hu; Ulrike Protzer; Aleem Siddiqui
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

9.  Testing the balanced electrostatic interaction hypothesis of hepatitis B virus DNA synthesis by using an in vivo charge rebalance approach.

Authors:  Pong Kian Chua; Fan-Mei Tang; Jyuan-Yuan Huang; Ching-Shu Suen; Chiaho Shih
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

10.  Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.

Authors:  Patricia M Day; Carl C Baker; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.